ArticleBiosensors2025
A Highly Sensitive SERS Technique Based on Au NPs Monolayer Film Combined with Multivariate Statistical Algorithms for Auxiliary Screening of Postmenopausal Osteoporosis.
Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Postmenopausal osteoporosis (PMOP) has become an important public health issue. The diagnosis of PMOP relies on clinical symptoms and radiology. However, most patients with PMOP do not exhibit obvious symptoms in the early stages of this disease. This study aimed to explore the feasibility of surface-enhanced Raman scattering (SERS) technology in the auxiliary screening of PMOP. PMOP rats were induced by ovariectomy (OVX) surgery, with a Sham group and an icariin (ICA) treatment group serving as controls. A monolayer film of Au nanoparticles (NPs) was prepared using the Marangoni effect in an oil/water/oil three-phase system, and was used to detect serum SERS signals in the Sham, OVX, and ICA treatment groups. Then, the spectral diagnostic model for PMOP screening was established utilizing partial least squares (PLS) and support vector machine (SVM) algorithms. Histopathology confirmed the establishment of the PMOP rat model. The assignment of Raman peaks and the analysis of spectral differences revealed the biochemical changes associated with PMOP, including the upregulation of tyrosine levels and the downregulation of arginine, tryptophan, lipids, and collagen. When employing the PLS-SVM algorithm to simultaneously classify and discriminate three groups of samples, the diagnostic sensitivity for PMOP is 93.33%, the specificity is 96.67%, and the accuracy of three-class classification is 91.11%. This study demonstrated the potential of SERS for the auxiliary screening of PMOP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.